Monitor DCOY's stock price post-split to ensure it maintains above $1.00 to achieve Nasdaq compliance; watch for potential liquidity challenges due to reduced share count and higher per-share price
Price Chart
Executive Summary
Decoy Therapeutics Inc. (DCOY) announced a 1-for-12 reverse stock split effective March 6, 2026, reducing outstanding shares from approximately 6.38 million to 532,000. The move is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing.
Key Facts
- Decoy Therapeutics is implementing a 1-for-12 reverse stock split effective March 6, 2026
- Outstanding shares will decrease from ~6.38 million to ~532,000
- The reverse split is designed to regain compliance with Nasdaq's $1.00 minimum bid price listing requirement
- The stock will begin trading on a split-adjusted basis on March 9, 2026 under the same ticker DCOY
- Authorized shares remain at 100 million; par value unchanged at $0.0001 per share
Financial Impact
No change to market capitalization or financial fundamentals; share count reduced from 6.38M to 532K with proportional price increase
Risk Factors
- Failure to sustain post-split price above $1.00 could lead to delisting
- Reduced liquidity from lower share count may deter some investors
- Reverse split may be perceived negatively by market as a sign of financial distress
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-092748 |
| Document: dcoy-ex99_1.htm | 0001193125-26-092748 |
| Document: dcoy-ex3_1.htm | 0001193125-26-092748 |
| Document: 0001193125-26-092748-index-headers.html | 0001193125-26-092748 |
| Document: 0001193125-26-092748-index.html | 0001193125-26-092748 |
| Document: 0001193125-26-092748.txt | 0001193125-26-092748 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | EFFECT | $1.17 $0.9100 | ▼ −22.22% | ▼ −22.08% | $1.03 (−11.97%) |
Oct 7, 2026 20d ago | S-1 | $1.52 $1.23 | ▲ +19.08% | ▲ +18.80% | $1.03 (+32.24%) |
Sep 23, 2026 4w ago | 8-K | $3.11 $1.86 | ▲ +40.35% | ▲ +39.94% | $1.03 (+66.88%) |
Aug 4, 2026 12w ago | DEFA14A | $4.19 $3.60 | ▼ −14.08% | ▼ −14.43% | $1.03 (−75.42%) |
Jul 20, 2026 14w ago | EFFECT | $5.31 $3.74 | ▼ −29.50% | ▼ −29.10% | $1.03 (−80.58%) |
Jun 29, 2026 17w ago | 8-K | $9.59 $7.25 | ▲ +24.40% | ▲ +25.79% | $1.03 (+89.26%) |
Jun 25, 2026 17w ago | EFFECT | $5.92 $7.62 | ▲ +28.76% | ▲ +27.20% | $1.03 (−82.60%) |
Jun 4, 2026 20w ago | DEFA14A | $6.71 $5.90 | ▼ −12.07% | ▼ −9.52% | $1.03 (−84.65%) |
Apr 30, 2026 25w ago | 10-K/A | $6.05 $6.01 | ▼ −0.66% | ▼ −2.39% | $1.03 (−82.98%) |
Apr 2, 2026 29w ago | 8-K | $5.80 $5.84 | ▲ +0.69% | ▼ −2.93% | $1.03 (−82.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers